SOPHARMA AD: Publication of Annual consolidated audited financial report of "Sopharma" AD for 2023 in ESF format

2024-04-25 13:31

publikacja
2024-04-25 13:31

Spis treści:

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
097900BGGW0000048796-20231231-EN-CON.zip (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		22	/	2024
Date of issue:	2024-04-25
Short name of the issuer
SOPHARMA AD
Subject
Publication of Annual consolidated audited financial report of "Sopharma" AD for 2023 in ESF format
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Publication of Annual consolidated audited financial report of "Sopharma" AD for 2023 in ESF format., Notification for Publication of Annual consolidated audited financial report of "Sopharma" AD for 2023 in ESF format., Annual consolidated audited financial report of "Sopharma" AD for 2023 in BFSC format
Annexes
File			Description
097900BGGW0000048796-20231231-EN-CON.zip097900BGGW0000048796-20231231-EN-CON.zip			Publication of Annual consolidated audited financial report of "Sopharma" AD for 2023 in ESF format

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2024-04-25	Ognian Donev	Executive Director

Ważne linki